ArticleJournal of the International AIDS Society2026
Evaluating an Implementation Strategy Bundle in Title X-Funded Safety-Net Family Planning Clinics to Increase HIV Testing and PrEP Access Among Cis-Gender Women in Atlanta, United States: Lessons Learned From Provider Focus Groups.
Article in Journal of the International AIDS Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The State of HIV-Related Implementation Research in 2026: Lessons Learned and Future Directions.Journal of the International AIDS Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
introductionPre-exposure prophylaxis (PrEP) remains underutilized by women in the United States, in part because PrEP is not widely available in women's healthcare settings. We developed a bundle of tailored implementation strategies (trainings, technical assistance [TA], resources) to support HIV prevention delivery in Title X-funded family planning clinics across Atlanta, Georgia (GA). Guided by the interactive systems framework, we partnered with GA's largest Title X grant holder to provide these strategies to this network. We conducted an evaluation of clinic strategy use and described pre- and post-strategy engagement HIV prevention/PrEP practices.
methodsUsing a qualitative descriptive design, between January 2022 and November 2023, 47 staff, providers and leadership from 11 clinical groups representing 22 of 31 Atlanta Title X clinics (71%) separately participated in baseline (pre-strategy) focus groups (FGs); 10 groups participated in FGs 1-year post-strategy(s). Rapid qualitative analysis of FGs was performed. Chart-abstracted measures were used to describe clinical group-aggregate HIV testing numbers 1 year prior to and 1 year after implementation strategy engagement.
resultsTwenty-two trainings were provided (n = 358 participants), with two TA and 53 requests received across 11 clinical groups. Clinics reported training and resource implementation strategies were acceptable and helped increase their readiness/capacity to provide PrEP, but scheduling trainings was sometimes challenging. Due to significant staff turnover, many noted that refresher trainings were or would be beneficial. TA was underutilized despite its potential need by clinical groups. At baseline, few clinics (<5; 22%) were providing PrEP. At follow-up, eight clinical groups were offering PrEP; one offered referrals to a PrEP-specific clinic. Three groups were able to provide injectable PrEP; two groups were not offering PrEP consistently or at all. Most groups (8 of 11; 73%) reported increases in total HIV tests in the 12 months after strategy engagement.
conclusionsImplementation strategies were utilized by clinics. Tailored trainings and resources were perceived as helpful for improving HIV testing, and PrEP provision in family planning settings and sustainable access to them via a centralized agency may be necessary to overcome ongoing capacity-related barriers. Additional strategies are necessary to ensure clinics are aware of and feel comfortable accessing the implementation strategies over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.